Overview
Research indicates that urolithin A, a compound metabolized from constituents found in pomegranates, walnuts, and certain berries, demonstrated significant improvements in cardiac function. This compound enhanced measures of heart function by up to 80% in animal models affected by a difficult-to-treat form of heart failure. Specific benefits observed included the relaxation of stiff heart tissue, a reduction in scarring, and a decrease in abnormal cardiac enlargement. Furthermore, urolithin A was shown to improve relaxation capabilities in engineered human heart tissue.
Findings
- Urolithin A improved measures of heart function by up to 80% in animal models of a difficult-to-treat form of heart failure.
- The compound helped stiff heart tissue relax.
- Urolithin A reduced scarring in heart tissue.
- It mitigated abnormal enlargement of heart tissue.
- Urolithin A improved relaxation in engineered human heart tissue.
Why This Matters
The observed effects of urolithin A in improving heart function, particularly in relaxing stiff heart tissue, reducing scarring, and diminishing abnormal enlargement within animal models of a challenging heart failure type, as well as its positive impact on engineered human heart tissue, suggest potential therapeutic relevance for cardiac health.